-
1
-
-
43749091268
-
Adverse drug reaction reporting by patients in the Netherlands: three years of experience
-
de Langen J, van Hunsel F, Passier A, et al. Adverse drug reaction reporting by patients in the Netherlands: three years of experience. Drug Saf 2008; 31(6): 515-24.
-
(2008)
Drug Saf
, vol.31
, Issue.6
, pp. 515-524
-
-
de Langen, J.1
van Hunsel, F.2
Passier, A.3
-
2
-
-
70349970392
-
Consumer reporting of adverse drug reactions: a retrospective analysis of the Danish adverse drug reaction database from 2004 to 2006
-
DOI: 10.2165/11316680-000000000-00000
-
Aagaard L, Nielsen LH, Hansen EH. Consumer reporting of adverse drug reactions: a retrospective analysis of the Danish adverse drug reaction database from 2004 to 2006. Drug Saf 2009; 32(11): 1067-74. DOI: 10.2165/11316680-000000000-00000
-
(2009)
Drug Saf
, vol.32
, Issue.11
, pp. 1067-1074
-
-
Aagaard, L.1
Nielsen, L.H.2
Hansen, E.H.3
-
3
-
-
77955570230
-
Adverse drug reaction reporting in the UK: a retrospective observational comparison of yellow card reports submitted by patients and healthcare professionals
-
DOI: 10.2165/11536510-000000000-00000
-
McLernon DJ, Bond CM, Hannaford PC, et al. Adverse drug reaction reporting in the UK: a retrospective observational comparison of yellow card reports submitted by patients and healthcare professionals. Drug Saf 2010; 33(9): 775-88. DOI: 10.2165/11536510-000000000-00000
-
(2010)
Drug Saf
, vol.33
, Issue.9
, pp. 775-788
-
-
McLernon, D.J.1
Bond, C.M.2
Hannaford, P.C.3
-
4
-
-
79951986271
-
The proportion of patient reports of suspected ADRs to signal detection in the Netherlands: case-control study
-
DOI: 10.1002/pds.2092
-
van Hunsel F, Talsma A, van Puijenbroek E, et al. The proportion of patient reports of suspected ADRs to signal detection in the Netherlands: case-control study. Pharmacoepidemiol Drug Saf 2011; 20(3): 286-91. DOI: 10.1002/pds.2092
-
(2011)
Pharmacoepidemiol Drug Saf
, vol.20
, Issue.3
, pp. 286-291
-
-
van Hunsel, F.1
Talsma, A.2
van Puijenbroek, E.3
-
5
-
-
77949407113
-
The missing voice of patients in drug-safety reporting
-
Basch E. The missing voice of patients in drug-safety reporting. N Engl J Med 2010; 362(10): 865-9.
-
(2010)
N Engl J Med
, vol.362
, Issue.10
, pp. 865-869
-
-
Basch, E.1
-
6
-
-
80053917697
-
The importance of direct patient reporting of suspected adverse drug reactions: a patient perspective
-
DOI 10.1111/j.1365-2125.2011.03990.x
-
Anderson C, Krska J, Murphy E, et al. The importance of direct patient reporting of suspected adverse drug reactions: a patient perspective. Br J Clin Pharmacol 2011; 72(5): 806-22. DOI 10.1111/j.1365-2125.2011.03990.x
-
(2011)
Br J Clin Pharmacol
, vol.72
, Issue.5
, pp. 806-822
-
-
Anderson, C.1
Krska, J.2
Murphy, E.3
-
7
-
-
84872156028
-
-
Directive 2010/84/EU. Official Journal of the European Union. Dec 31;L. 348-74-99.
-
Directive 2010/84/EU. Official Journal of the European Union 2010. Dec 31;L. 348-74-99.
-
(2010)
-
-
-
8
-
-
84872148824
-
-
Regulation 1235/2010. Official Journal of the European Union 10 A.D. Dec 31;L. 348-1-16.
-
Regulation 1235/2010. Official Journal of the European Union 10 A.D. 2010. Dec 31;L. 348-1-16.
-
(2010)
-
-
-
9
-
-
79955140231
-
Getting to grips with the new European Union pharmacovigilance legislation
-
DOI: 10.1002/pds.2119
-
Waller P. Getting to grips with the new European Union pharmacovigilance legislation. Pharmacoepidemiol Drug Saf 2011; 20(5): 544-9. DOI: 10.1002/pds.2119
-
(2011)
Pharmacoepidemiol Drug Saf
, vol.20
, Issue.5
, pp. 544-549
-
-
Waller, P.1
-
10
-
-
79951788370
-
Strengthening and rationalizing pharmacovigilance in the EU: where is Europe heading to? A review of the new EU legislation on pharmacovigilance
-
DOI: 10.2165/11586620-000000000-00000
-
Borg JJ, Aislaitner G, Pirozynski M, et al. Strengthening and rationalizing pharmacovigilance in the EU: where is Europe heading to? A review of the new EU legislation on pharmacovigilance. Drug Saf 2011; 34(3): 187-97. DOI: 10.2165/11586620-000000000-00000
-
(2011)
Drug Saf
, vol.34
, Issue.3
, pp. 187-197
-
-
Borg, J.J.1
Aislaitner, G.2
Pirozynski, M.3
-
11
-
-
79951822353
-
Intensive Monitoring of Pregabalin Results from an Observational, Web-Based, Prospective Cohort Study Using Patients as a Source of Information
-
DOI: 10.2165/11585030-000000000-00000
-
Härmark L, van Puijenbroek E, Straus S, et al. Intensive Monitoring of Pregabalin Results from an Observational, Web-Based, Prospective Cohort Study Using Patients as a Source of Information. Drug Saf 2011; 34(3): 221-31. DOI: 10.2165/11585030-000000000-00000
-
(2011)
Drug Saf
, vol.34
, Issue.3
, pp. 221-231
-
-
Härmark, L.1
van Puijenbroek, E.2
Straus, S.3
-
12
-
-
79959543811
-
Longitudinal monitoring of the safety of drugs by using a web-based system: the case of pregabalin
-
DOI: 10.1002/pds.2135
-
Härmark L, van Puijenbroek E, van Grootheest K. Longitudinal monitoring of the safety of drugs by using a web-based system: the case of pregabalin. Pharmacoepidemiol Drug Saf 2011; 20(6): 591-7. DOI: 10.1002/pds.2135
-
(2011)
Pharmacoepidemiol Drug Saf
, vol.20
, Issue.6
, pp. 591-597
-
-
Härmark, L.1
van Puijenbroek, E.2
van Grootheest, K.3
-
13
-
-
84555190232
-
Web-based Intensive Monitoring, from passive to active drug surveillance
-
Härmark L, van Grootheest AC. Web-based Intensive Monitoring, from passive to active drug surveillance. Expert Opin Drug Saf 2012; 11(1): 45-51.
-
(2012)
Expert Opin Drug Saf
, vol.11
, Issue.1
, pp. 45-51
-
-
Härmark, L.1
van Grootheest, A.C.2
-
14
-
-
78649316137
-
Motives for reporting adverse drug reactions by patient-reporters in the Netherlands
-
van Hunsel F, van der Welle C, Passier A, et al. Motives for reporting adverse drug reactions by patient-reporters in the Netherlands. Eur J Clin Pharmacol 2010; 66(11): 1143-50.
-
(2010)
Eur J Clin Pharmacol
, vol.66
, Issue.11
, pp. 1143-1150
-
-
van Hunsel, F.1
van der Welle, C.2
Passier, A.3
-
15
-
-
34447104848
-
Why, and how, mixed methods research is undertaken in health services research in England: a mixed methods study
-
O'Cathain A, Murphy E, Nicholl J. Why, and how, mixed methods research is undertaken in health services research in England: a mixed methods study. BMC Health Serv Res 2007; 7: 85.
-
(2007)
BMC Health Serv Res
, vol.7
, pp. 85
-
-
O'Cathain, A.1
Murphy, E.2
Nicholl, J.3
-
16
-
-
52649147608
-
Critically appraising qualitative research
-
DOI: 10.1136/bmj.a1035
-
Kuper A, Lingard L, Levinson W. Critically appraising qualitative research. BMJ 2008; 337: a1035. DOI: 10.1136/bmj.a1035
-
(2008)
BMJ
, vol.337
-
-
Kuper, A.1
Lingard, L.2
Levinson, W.3
-
17
-
-
84872122624
-
-
Survey Monkey. (accessed 05-01-2011).
-
Survey Monkey. www.surveymonkey.com (accessed 05-01-2011).
-
-
-
-
18
-
-
84872162910
-
-
Dutch National Institute of Public Health and the Environment. Hoe vaak komt diabetes mellitus voor en hoeveel mensen sterven eraan? / (Accessed 05-12-2011).
-
Dutch National Institute of Public Health and the Environment. Hoe vaak komt diabetes mellitus voor en hoeveel mensen sterven eraan? 2011. http://www.nationaalkompas.nl/gezondheid-en-ziekte/ziekten-en-aandoeningen/endocriene-voedings-en-stofwisselingsziekten-en-immuniteitsstoornissen/diabetes-mellitus/omvang/ (Accessed 05-12-2011).
-
(2011)
-
-
-
19
-
-
84872162449
-
-
Trends in Beeld. Opleidingsniveau van de Nederlandse bevolking. (Accessed 05-12-2011).
-
Trends in Beeld. Opleidingsniveau van de Nederlandse bevolking. http://www.trendsinbeeld.minocw.nl/grafieken/3_1_2_31.php (Accessed 05-12-2011).
-
-
-
-
20
-
-
0030787122
-
Consumer participation in research and health care
-
Liberati A. Consumer participation in research and health care. BMJ 1997; 315(7107): 499.
-
(1997)
BMJ
, vol.315
, Issue.7107
, pp. 499
-
-
Liberati, A.1
-
21
-
-
33846120161
-
Routledge PA. Patient reporting of suspected adverse drug reactions: a review of published literature and international experience
-
Blenkinsopp A, Wilkie P, Wang M, et al. Routledge PA. Patient reporting of suspected adverse drug reactions: a review of published literature and international experience. Br J Clin Pharmacol 2007; 63(2): 148-56.
-
(2007)
Br J Clin Pharmacol
, vol.63
, Issue.2
, pp. 148-156
-
-
Blenkinsopp, A.1
Wilkie, P.2
Wang, M.3
|